We would love to hear your thoughts about our site and services, please take our survey here.
Am figuring that the low valuation reflects perceived risks, either regulatory or overhang (ex CEO’s holding). Feels as if patience will be a virtue here
Or if it’s not going well Dad would need to pony up some working capital. All speculation as nobody knows the truth. It could be that he can’t stomach the risk in UTW anymore
Because they need the money. Can be a divorce or cash flow problems.
The toothbrush is interesting but i’m Interested in the price point. Will it be competitive...I don’t see why price should be different. Having read posts below. I recall one of the other times I was interested in Sym. (I said a few months ago that the share is a serial disappointment and here we are back in single digits) Tesco used to incorporate D2W, or its predecessor in their bags...but then they dropped it like a stone all of a sudden. I never knew why as the Symphony management never mentioned it. Public opinion has of course moved on since then. I would love to see degradable bags but this issue tempers any excitement
For every seller there has to be a buyer. It would appear that a large discount was required to take on the risk. This is v illiquid and will continue to fall in a news vacuum. If something even marginally +ve were to transpire the illiquidity would be a strong tailwind for holders
Closed period??
If they achieve £10m of free cash flow in 2021 that’s almost half the current market cap
Share price reaction to recent news that there appears to be some connection between gene editing and cancer appearing is interesting. As this outcome is disputed perhaps it poo ts to a requirement for greater rigour in research via HZD tools
Even I thought that Abcam would be a possible suitor a long time ago. Worth noting that management have previously piled in when the shares have gam fallen sharply. They know the value of the business more than most so it is good to see them getting involved. If the offer is successfully rebuffed because they feel they can realise better value independently then he could hardly be accused
Sorry, should have said....until recently! This company has been characterized by a number of spurts of promise followed by serial disappointments. The tone around plastic has changed so let’s hope it finally comes good. I have taken a small punt.
On the face of it, this sounds like a complimentary tie up. No indication of what volumes can be achieved or when money can be made. There is some IP in there! I still remember the foray into tyre shredding which was a waste of shareholders money. I was also invested way back when d2w was a component of Tesco carrier bags. I was surprised when they ditched it. There is a mimics bigger prize now given the volume of plastics clogging up the aisles. SYM has been full of promise for over a decade. The opportunity cost of being a long term holder has so far been huge!
I have been a long term follower of this co and have held it on several occasions. However, I can’t shake my concern that rules on plastic will change and SYM will be left behind as better financed companies get involved. Symphony may have the D2P brand name but it doesn’t hold IP. How come none of the micro cap institutions haven’t appeared on the shareholder register? Seems odd
Not sure that it’s down to shorting. Issues with Facebook and Google happened post the results and nothing has actually happened to alter their bus models and by extension Taptica’s. Market justifiably discounting increased risk of regulation that may or may not materialise.
The cash call happened in response to Dharmacon acquisition. The balance sheet is actually quite robust. This is what happens when people sell illiquid shares
Just a liquidity vacuum i’d say. If the USD steadies the earnings headwind diminishes. Very few buying at the mo. At some point there should be a large bounce. Exceeding expectations at next update would help a lot given co is on cusp of profitability
The update was a little light in detail. No comment on revenue or profit/loss. The company can’t brief anyone on this until the market informed. Thus not expecting headway until results unless there are materially earnings +ve announcements in the interim
Tuesday
Why is anyone surprised that the share price has become volatile at the multiple that it’s trading at?? The company has to keep knocking out excellent performance to justify it. Any selling is magnified by low liquidity. The reverse applies when there are buyers
I think that it is undeniably over valued but highly likely to remain so given both popularity of sector and co's market position. The lack of volatility is surprising but should be seen in wider market context of low vol. the company needs amazing results to justify expectations reflected in valuation and it just might. Not just about revenue growth...once break even achieved margins are huge
this link gives some indication of what the software does. given the extent of the commitments being made to the product from numerous customers and technology businesses it is probably time to question why you could possibly be right and everyone else, including many 100's of corporate IT buyers, is wrong https://www.blueprism.com/news/artificial-intelligence/blue-prism-announces-availability-worlds-most-advanced-digital-workforce nobody is disputing that the valuation is frightening